As of Oct 22
| -0.53 / -0.96%|
The 15 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 68.00, with a high estimate of 120.00 and a low estimate of 19.00. The median estimate represents a +24.25% increase from the last price of 54.73.
The current consensus among 17 polled investment analysts is to Hold stock in Ionis Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.